MET and brain neoplasm: Studies have shown that miR-34a suppresses brain tumor growth by targeting c-Met and Notch [25], suppresses proliferation and migration through the down-regulation of c-Met in uveal melanoma cells [26], and inhibits migration and invasion through down-regulation of c-Met expression in human hepatocellular carcinoma cells [24].